Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists from the CIMA from the University of Navarra investigate a molecule for diagnosing hypertensive cardiopathy

10.05.2007
Scientists from the Center for Applied Medical Research (CIMA) from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.

After studying the relationship of this molecule with this disease, the experts believe that cardiotrophin 1 is useful for preventing or controlling the damaging effects on the heart suffered by patients with this disease. In Spain, there are four million patients with this illness, a number that supposes fifty percent of the eight million patients with high blood pressure.

The research on this cardiovascular illness was shared today during the course of the International Congress Frontiers in Transnational Research of Cardiovascular Diseases, held in the CIMA, and in which dozens of Spanish, Germans, British and Dutch scientists participated.

Currently, these types of illnesses are the number one cause of doctor’s visits, hospitalization and death worldwide. As it is foreseen that their frequency will increase in the next decades, experts propose the soonest possible application of the latest biomedical and biotechnological advances for the diagnosis, prevention and treatment of these pathologies.

Stroke and Atrial Fibrillation Prevention

Cardiotrophin 1 as it intervenes in the earliest phases of hypertensive cardiopathy, if we act on it we can prevent complications such as cardiac insufficiency, atrial fibrillation, strokes and even patient death.

The speakers also touched on aspects of high blood pressure, which affects more than 25% of the adult population. For example, they revised the advances in the diagnosis and treatment of lesions that this pathology produces in the heart, the brain and the kidneys, saying that is one of the primary causes of problems such as cardiac insufficiency, vascular dementia and kidney failure.

In addition, they studied the harmful impact of diabetes and obesity on the heart and the arteries. In this sense, they presented pharmaceutical advances that can lead to a revolution in the current therapy used. Finally, they spoke of atherosclerosis (arterial hardening), the most common illness and with the worst consequences. They also analyzed the use of biomarkers for early detection of future strokes (whether cerebral or heart attacks) and cellular therapy in order to minimize its consequences.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&hizk=I&Berri_Kod=1309

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>